Category Archives: Uncategorized

Cranial neuropathy soon after COVID-19 onset

This study describes 2 patients who developed cranial neuropathies within days of presenting with SARS-CoV-2-related respiratory symptoms. Source: AAO

Posted on: Jun 9 2020
By: Saratoga Opthalmology
Leave a response

David Aizuss elected to AMA board of trustees

The American Medical Association (AMA) has elected David H. Aizuss, MD, to its board of trustees. Source: AAO

Posted on: Jun 8 2020
By: Saratoga Opthalmology
Leave a response

Safety review committee releases report on inflammation events due to brolucizumab

The incidence of retinal vasculitis and retinal vascular occlusion after brolucizumab injections are higher than originally reported, according to a post-hoc review of the phase 3 HAWK and HARRIER trials. Source: AAO

Posted on: Jun 8 2020
By: Saratoga Opthalmology
Leave a response

Diclofenac might be unnecessary for post-SLT management

This prospective, double-blind, randomized, placebo-controlled trial compared the effect of apraclonidine and diclofenac on IOP changes after selective laser trabeculoplasty (SLT). Source: AAO

Posted on: Jun 8 2020
By: Saratoga Opthalmology
Leave a response

Employment Opportunity-Executive Director (Medical Services Manager)

Saratoga Ophthalmology in Malta, NY, seeks an Executive Director (Medical Services Manager) to plan, direct, and coordinate medical services in ophthalmologist offices. Develop, implement and monitor business operations plans to improve efficiency and quality in delivering healthcare services; Develop departmental goals and objectives and implement a budget to achieve organizational objectives; Recruit, train, and supervise […]

Posted on: Jun 3 2020
By: Saratoga Ophthalmology

Week in review: Bionic ball, clever computers, depressed docs

This week, researchers develop the most impressive bionic eye to date, DeepMind outperforms human experts in diagnosing AMD and a study reveals high levels of depression among Indian ophthalmologists during the pandemic. Source: AAO

Posted on: May 29 2020
By: Saratoga Opthalmology
Leave a response

Keratoconjunctivitis could present as initial COVID-19 symptom

This is the first case report of COVID-19 with keratoconjunctivitis as the main presenting symptom. Source: AAO

Posted on: May 29 2020
By: Saratoga Opthalmology
Leave a response

Intraoperative angle kappa adjustments during SMILE may limit higher order aberrations

Investigators compared higher-order aberrations after small incision lenticule extraction in patients with and without intraoperative angle kappa adjustments. Source: AAO

Posted on: May 28 2020
By: Saratoga Opthalmology
Leave a response

Editorial highlights first case of conjunctivitis as initial presentation for COVID-19

This editorial addressed the necessary protection for healthcare workers against COVID-19, and discussed the possibility of conjunctivitis being a presenting sign of the disease. Source: AAO

Posted on: May 27 2020
By: Saratoga Opthalmology
Leave a response

Cyclosporine A cationic emulsion safe for pediatric vernal keratoconjunctivitis

This follow-up study further assessed the safety of cyclosporine A cationic emulsion in patients with pediatric vernal keratoconjunctivitis. Source: AAO